Practitioner Diversion Awareness Conference
November 9, 2018; Wayne State University Law School – Detroit, Michigan
The Drug Enforcement Administration (DEA) Detroit Field Division hosted Michigan’s first Practitioner Diversion Awareness Training at Wayne State University’s Law School on November 9, 2018 in Detroit, Michigan. The conference was developed and designed to address issues of diversion and abuse of pharmaceutical controlled substances.
Nearly 1,000 practitioners registered for the conference, to include physicians, nurse practitioners, physician assistants, dentists, and other DEA registrants. Practitioners attended the event either in person or via live stream. Conference attendees received nearly seven hours of information on a variety of topics. The presentations, given by both DEA and private instructors, included: DEA’s Diversion Control mission; Michigan Automated Prescription System and state legislative updates; the pathophysiology and neurological basis of addiction; CDC’s Guideline for Prescribing Opioids; health care fraud; methods of diversion and drug trends; reducing opioid prescribing; electronic prescribing; and Medication-Assisted Treatment.
Selected presentations from the Detroit, Michigan PDAC are below.
DEA Diversion Control Mission and Overview – Cathy A. Gallagher, Diversion Program Manager, DEA Detroit
Michigan Automated Prescription System and State Legislative Updates – Kim Gaedeke, Deputy Director, and Amber Daniels, MAPS Analyst, Michigan Department of Licensing and Regulatory Affairs
The Pathophysiology and Neurological Basis of Addiction – David Neff, DO, Chief Medical Director, Office of Medical Affairs, Medical Services Administration, Michigan Department of Health and Human Services
Managing Pain Safely and Effectively: CDC Guideline for Prescribing Opioids – Amy Bohnert, PhD, MS
Health Care Fraud and Diversion – Christopher Gould, Special Agent, US Department of Health and Human Services
Methods of Diversion and Drug Trends – Assistant Special Agent in Charge Kent Kleinschmidt and Special Agent William Chamulak, DEA Detroit
Reducing Opioid Prescribing – Bret Bielawski, DO, FACP
The Role of Electronic Prescribing in Reducing Diversion – Ewen Nicol, PA
Providing Opioid Addiction Treatment to Patients – Abdulhassan Saad, MD
DEA Initiatives and Next Steps – Cathy A. Gallagher, Diversion Program Manager, DEA Detroit
NOTE: Presentations by private instructors do not constitute an endorsement by the DEA of the presenters or their products or services.